Literature DB >> 31813109

Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients.

Adriano Guarnieri1, Elena Carnero1, Anne-Marie Bleau1, Belén Alfonso-Bartolozzi1, Javier Moreno-Montañés2.   

Abstract

PURPOSE: To evaluate the quality of life of glaucoma patients using the Ocular Surface Disease Index (OSDI) questionnaire and their association with dry eye clinical signs.
METHODS: The study included patients into three groups. The treated group diagnosed with bilateral open-angle glaucoma and treated with one or more topical medication at least 1 year. The operated group underwent glaucoma surgery without the need for topical medications. The control group entered subjects without ocular diseases or previous surgeries. Dry eye clinical signs were evaluated; noninvasive tear break-up time, Meibomian gland depletion (MGD), and conjunctival hyperemia were measured using the Keratograph 5 M. The total-OSDI (T-OSDI) score was divided into the visual field-OSDI and discomfort-OSDI scores.
RESULTS: Two hundred and nine subjects participated in this cross-sectional study, 147 using glaucoma medications, 21 patients underwent glaucoma surgery and 41 were controls. The T-OSDI and subscores were higher in glaucoma patients compared with controls (p < 0.05); we found no differences between treated and surgically groups. Correlations were observed between the T-OSDI values and Schirmer test (p = 0.016), ocular surface staining (p < 0.001) and the MGD (p = 0.006). The subscores were associated with the ocular surface staining (VF p = 0.013 and D p = 0.003). In treated patients, the number of drops per day correlates with T-OSDI and subscores (p = 0.017 and p = 0.005).
CONCLUSION: OSDI scores increased in the glaucoma patients compared to controls without significant changes between treated and surgical patients. OSDI scores were associated to dry eye signs and medication in glaucoma patients.

Entities:  

Keywords:  Glaucoma; Keratitis; Keratograph 5 M; Ocular Surface Disease Index; Quality of life

Mesh:

Substances:

Year:  2019        PMID: 31813109     DOI: 10.1007/s10792-019-01236-z

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  35 in total

1.  Ocular surface changes in eyes with glaucoma filtering blebs.

Authors:  Celso Ricardo Neves Mendes; Richard Yudi Hida; Niro Kasahara
Journal:  Curr Eye Res       Date:  2012-04       Impact factor: 2.424

2.  Evaluation of Quality of Life in Japanese Glaucoma Patients and its Relationship With Visual Function.

Authors:  Gen-ichiro Takahashi; Yasumasa Otori; Mitsuyoshi Urashima; Yasuaki Kuwayama
Journal:  J Glaucoma       Date:  2016-03       Impact factor: 2.503

3.  Topical anaesthetic and tear film stability.

Authors:  L S Mengher; K S Pandher; A J Bron
Journal:  Acta Ophthalmol (Copenh)       Date:  1986-02

Review 4.  Effects of Aging in Dry Eye.

Authors:  Cintia S de Paiva
Journal:  Int Ophthalmol Clin       Date:  2017

5.  Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project.

Authors:  Pradeep Y Ramulu; Sheila K West; Beatriz Munoz; Henry D Jampel; David S Friedman
Journal:  Ophthalmology       Date:  2009-07-09       Impact factor: 12.079

6.  Visual field loss increases the risk of falls in older adults: the Salisbury eye evaluation.

Authors:  Ellen E Freeman; Beatriz Muñoz; Gary Rubin; Sheila K West
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

7.  Patient satisfaction with glaucoma therapy: reality or myth?

Authors:  Hans G Lemij; Juliette Gmm Hoevenaars; Cees van der Windt; Christophe Baudouin
Journal:  Clin Ophthalmol       Date:  2015-05-04

8.  Conservative treatment for late-onset bleb leaks after trabeculectomy with mitomycin C in patients with ocular surface disease.

Authors:  Hideto Sagara; Tomohiro Iida; Kimimori Saito; Hiroki Noji; Masashi Ogasawara; Hiroshi Oyamada
Journal:  Clin Ophthalmol       Date:  2012-08-08

9.  Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma.

Authors:  Barbara Cvenkel; Špela Štunf; Irena Srebotnik Kirbiš; Margareta Strojan Fležar
Journal:  Clin Ophthalmol       Date:  2015-04-08

10.  Treatment with sodium hyaluronate eye drops in a patient who had early-onset bleb leakage after trabeculectomy with mitomycin C.

Authors:  Hideto Sagara; Tetsuju Sekiryu; Hiroki Noji; Masashi Ogasawara; Kimihiro Imaizumi; Keiko Yago
Journal:  Int Med Case Rep J       Date:  2015-11-27
View more
  5 in total

1.  Effects of Glaucoma Medication on Dry Eye Syndrome and Quality of Life in Patients with Glaucoma.

Authors:  Kyung Joo Maeng; Kwanghyun Lee; Sangah Kim; Chan Keum Park; Eun Woo Kim; Sang Yeop Lee; Hyoung Won Bae; Gong Je Seong; Chan Yun Kim
Journal:  Korean J Ophthalmol       Date:  2021-10-12

2.  Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease.

Authors:  Sang-Woo Park; Jiwoong Lee; Michael S Kook
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-07

3.  Intense pulsed light-based treatment for the improvement of symptoms in glaucoma patients treated with hypotensive eye drops.

Authors:  Jose Maria Martinez-de-la-Casa; Carlos Oribio-Quinto; Almudena Milans-Del-Bosch; Pilar Perez-Garcia; Laura Morales-Fernandez; Javier Garcia-Bella; Jose Manuel Benitez-Del-Castillo; Julian Garcia-Feijoo; David P Piñero
Journal:  Eye Vis (Lond)       Date:  2022-04-01

4.  Dry eye disease and tear film assessment through a novel non-invasive ocular surface analyzer: The OSA protocol.

Authors:  María Carmen Sánchez-González; Raúl Capote-Puente; Marta-C García-Romera; Concepción De-Hita-Cantalejo; María-José Bautista-Llamas; Carmen Silva-Viguera; José-María Sánchez-González
Journal:  Front Med (Lausanne)       Date:  2022-08-10

5.  Correlation of meiboscale symptom score and sign score for primary meibomian gland dysfunction in Indian eyes - A cross-sectional study.

Authors:  Prateek Nishant; Achala Ramawat; N Shrinkhal; Neeti Gupta; Sanjeev K Mittal
Journal:  Indian J Ophthalmol       Date:  2022-06       Impact factor: 2.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.